Vaccine Market Analysis And Forecast To 2032: By Age Group (Pediatric, Adult), By Disease (Cancer, Hepatitis, Pneumococcal Disease, DTP, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, COVID-19), By Technology (Conjugate, Live,

Vaccine Market Analysis And Forecast To 2032: By Age Group (Pediatric, Adult), By Disease (Cancer, Hepatitis, Pneumococcal Disease, DTP, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, COVID-19), By Technology (Conjugate, Live, Inactivated, Recombinant, Toxoid) And Region

The global Vaccine Market was valued at USD 135.4 Billion in 2022 and it is anticipated to grow up to USD 76.9 Billion by 2032, at a CAGR of 5.5% during the forecast period.

A vaccine is a biological which is used to boost the person immune system and help to provide immunization against chronic diseases. The suspension consists of either weakened or killed forms of disease-causing microorganisms that enhance immunity without causing diseases. The vaccine provides active immunity against a specific harmful agent such as diseases caused by a certain pathogen, injection, bacteria, virus, or parasites. By stimulating the immune system to attack the agent and eliminating these agents and increasing the life of adults and elderly individuals. After stimulation by a vaccine, B lymphocytes remain sensitized and ready to respond to the agent whenever it enters the body next time.

Global Vaccine Market Scope and Report Structure

Market Trends and Drivers

The expanding availability of preventive as well as therapeutic vaccines for range of diseases will boost the market expansion. Furthermore, newly emerging infectious pathogenic diseases has influenced the need for effective vaccines across the globe. This has driven the R&D activities undertaken by the operational players as well as dedicated research institutes. Advancement in vaccine development technologies to increase its efficacy and liability will offer innovative solutions to address existing disease burden. The adoption of novel development approaches including DNA/RNA vaccines, nanoparticle vaccines, and rational design will foster the vaccines market expansion.

Market Restraints and Challenges

Some of the market obstacles include a scarcity of experienced specialists and significant investment costs, as well as legal and ethical concerns about the market methods and outcomes in numerous nations.

Global Vaccine Market Segmental Overview

The report analyses the global Vaccine Market based on age group, technology, application, and region.

Global Vaccine Market by Age Group

Based on age group, the market is bifurcated into S Pediatric, and Adult. Adult vaccines segment is projected to proceed at xx% CAGR during the forecast timeframe. This is attributable to increased COVID-19 vaccination rate among adults. Moreover, the awareness and improving accessibility of various preventive vaccines that helps to reduce the risk of severe infections in adults will drive the segment revenue. Additionally, some countries have established the vaccination policies and regulations for adults while travelling to particular nations to avoid the risk of disease transmission, that has further influenced the vaccination rate in adults..

Global Vaccine Market by Technology

Based on the technology, the market is bifurcated into Conjugate, Live, Inactivated, Recombinant, Toxoid. Vaccines market from inactivated segment exceeded USD xx billion in 2022. This is attributed to the ability of inactivated vaccines in destruction of pathogen replication. This offers effective protection against various dreadful pathogenic diseases such as hepatitis A, influenza, polio, and rabies. Moreover, these vaccines prevent the reversal activity of pathogens to more pathogenic phenotype and avoids the interference with other functional molecules during the combination therapies. This leads to preference for inactivated technology over the live vaccines. Furthermore, as it can stored without refrigeration for certain period as the pathogen is dead, it offers ease in transportation and storage that will continue to increase its demand.

Global Vaccine Market by Application

Based on the application, the market is bifurcated into Cancer, Hepatitis, Pneumococcal Disease, Influenza, Rotavirus, COVID-19, and others. The higher recommendation of HPV vaccination for preteens, teens as well as younger adults as it can lead to different types of cancer will enhance the industry landscape. For instance, as per the Centers for Disease Control and Prevention, each year, nearly 14 million Americans, including teens are anticipated to be infected with HPV. The vaccination also prevents the risk of cervical cancer development in women. Thus, increasing vaccination rate across the developed and developing regions to reduce further risk of severe diseases associated with HPV will stimulate the market statistics.

Geographical Analysis of Global Vaccine Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. Europe vaccines market accounted for xx% revenue share in 2022. This is attributable to the adoption of new technologies and expanding awareness about the preventive vaccines in the region. The government organizations are implementing some strategies to broaden accessibility for the emerging infectious disease treatments including the COVID-19. In addition, the industry players entered in collaboration with non-government organizations to provide COVID-19 vaccines considering significantly increasing disease incidence in the region.

Major Players in the Global Vaccine Market

The global Vaccine Market report includes players are AstraZeneca plc., CSL Limited, Emergent BioSolutions Inc., GlaxoSmithKline plc., Johnson & Johnson, Merck & Co., Novavax, Pfizer Inc, Sanofi S.A., and Serum Institute of India, among others.

COVID-19 Impact:

The outbreak of the COVID-19 pandemic pushed the pharmaceutical industry into action, with a race to develop therapeutic and preventive interventions. The onset of the SARS-CoV-2 pandemic set many pharmaceutical companies to quickly add clinical sequencing to expand safety testing that helped fight against the COVID-19 pandemic. COVID-19 had a significant impact on the Vaccine market. For instance, as per the study published in PLOS ONE in January 2022, it was concluded that COVID-19 syndrome caused significant alterations in the blood transcriptome, which were assessed using RNAseq and verified using digital droplet PCR (ddPCR) on specific targets. Such studies augment the use of Vaccine in analyzing the progression of COVID-19, thereby boosting the market's growth over the coming years. Hence, owing to the increasing RNA and DNA sequencing-based research & development activities in developing diagnostic tools or effective therapeutics for COVID-19, the market is likely to continue its significant growth rate during the forecast period.

Recent Developments:

In February 2021, Ceva partnered with the French National Research Institute for Agriculture, Food, and Environment (INRAE) for R&D in the prevention of infectious diseases from animal origin and improvement of animal health.

In January 2021, Zoetis launched the Poulvac Procerta HVT-IBD vaccine for the protection of poultry against Infectious Bursal Disease (IBD). This added to the company line of recombinant vector vaccines.

UNICEF and Pfizer entered into a supply agreement for the COVID-19 vaccines distribution throughout 2021. This has helped the company to maintain broaden its distribution across the globe, thereby driving the business revenue.



Frequently Asked Questions

Q1. How big is the Vaccine Market?

Ans. The global Vaccine Market was valued at USD 135.4 Billion in 2022 and it is anticipated to grow up to USD 76.9 Billion by 2032, at a CAGR of 5.5% during the forecast period.

Q2. What is the Vaccine Market growth rate?

Ans. The growth rate of the Vaccine market is 5.5%

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Vaccine Market in 2022.

Q4. Which segment accounted for the largest Vaccine Market share?

Ans. By application, the COVID-19 segment accounted for the largest Vaccine Market share.

Q5. Who are the key players in the kidney stones management market?

Ans. The global Vaccine Market report includes players are GlaxoSmithKline, Abbott, Astellas Pharma, Inc., AstraZeneca, Serum Institute of India, CSL Limited, Emergent BioSolutions, Inc., Merck & Co. Inc., Novavax, Pfizer, and Sanofi among others.

Q6. What are the factors driving the Vaccine Market growth?

Ans. The newly emerging infectious pathogenic diseases has influenced the need for effective vaccines across the globe are expected to drive global market revenue growth.

Q7. What are the key growth strategies of Vaccine Market players?

Ans. The key growth strategies of Vaccine Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Vaccine Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Vaccine Market during the forecast period.


Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.